Summary not available.
Summary not available.
Summary not available.
Tekla Healthcare Investors (NYSE: HQH) has announced a renewal of its share repurchase program, allowing for the purchase of up to 12% of its outstanding common shares in the open market. This program will run for one year, ending July 14, 2024. The initiative aims to enhance shareholder value and potentially close the gap between the fund's market price and its net asset value. The timing and amount of repurchases will be determined by Tekla Capital Management LLC, the fund's investment adviser. While the program is designed to increase net asset value and provide liquidity, there is no guarantee of any specific outcome.
BOSTON--(BUSINESS WIRE)--On February 15, 2023, Tekla Healthcare Investors (NYSE:HQH) announced a distribution of $0.42 per share. The record date for this distribution is February 27, 2023, with a payable date of March 31, 2023. The Fund will trade ex-distribution on February 24, 2023. Following the Fund's policy, quarterly distributions will be 2% of net assets, meaning that the distribution amount may vary depending on asset fluctuations. Shareholders can opt for cash payments instead of shares by the March 22, 2023 deadline. The Fund invests in the healthcare sector, managed by Tekla Capital Management LLC.
On November 15, 2022, Tekla Healthcare Investors (NYSE: HQH) announced a distribution of $0.39 per share. The record date is November 25, 2022, with payments due on December 30, 2022. The shares will trade ex-distribution on November 23, 2022. The Fund will distribute quarterly at a rate of 2% of net assets, affecting share amounts based on asset fluctuations. Distributions will default to new shares unless shareholders opt for cash, with requests due by December 20, 2022.
On August 16, 2022, Tekla Healthcare Investors announced a distribution of $0.40 per share, with a record date of August 26, 2022 and a payable date of September 30, 2022. The Fund will trade ex-distribution on August 25, 2022. Following its distribution policy, the Fund aims for quarterly distributions at 2% of its net assets. This distribution will automatically be paid in newly issued shares unless shareholders opt for cash by the set deadlines. Tekla Healthcare Investors operates as a closed-end Fund investing in healthcare companies.
On May 17, 2022, org value="NYSE:HQH"Tekla Healthcare Investors announced a distribution of $0.44 per share, with a record date of May 27, 2022 and a payable date of June 30, 2022. The shares will trade ex-distribution on May 26, 2022. Shareholders will receive newly issued shares unless otherwise specified, valued at the lower of net asset value or market price on June 22, 2022. Cash payment requests for shares in 'street name' must be made through the respective brokerage.
Tekla Healthcare Investors (NYSE: HQH) announced the renewal of its share repurchase program, allowing the purchase of up to 12% of its outstanding common shares over the next year, ending on July 14, 2023. This initiative aims to enhance shareholder value and minimize the market price discount to the fund’s net asset value per share. The timing and amount of repurchases will be at the discretion of Tekla Capital Management LLC. Although the program aims to improve liquidity and net asset value, there is no guarantee that share repurchases will increase market prices.
On February 15, 2022, Tekla Healthcare Investors announced a distribution of $0.48 per share. The record date is set for February 25, 2022, with a payable date on March 31, 2022. Shares will trade ex-distribution on February 24, 2022. The distribution will primarily be paid in newly issued shares of the fund, valued at the lower of the net asset value or market price on March 23, 2022. Shareholders can opt for cash instead of shares by following specific instructions. Tekla Healthcare Investors focuses on investments in the healthcare sector.